CD44 and cancer: Since NSCLC/HCC-derived NPC was shown to express the HA receptor CD44 in this study, we therefore examined its role in pericyte metabolic reprogramming, indicating that blockade of HA fragments prohibited the up-regulation of HK2 and ROCK2 expression in NPC after exposure with conditioned medium from cancer cells.